Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8290662rdf:typepubmed:Citationlld:pubmed
pubmed-article:8290662lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:8290662lifeskim:mentionsumls-concept:C0525045lld:lifeskim
pubmed-article:8290662lifeskim:mentionsumls-concept:C0013175lld:lifeskim
pubmed-article:8290662lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:8290662lifeskim:mentionsumls-concept:C0392762lld:lifeskim
pubmed-article:8290662pubmed:issue2lld:pubmed
pubmed-article:8290662pubmed:dateCreated1994-2-23lld:pubmed
pubmed-article:8290662pubmed:abstractTextThis article presents a metaanalysis of approximately 300 studies of drug treatment for affective disorders. Efficacy is proven beyond a shadow of a doubt in this overview from random-assignment, double-blind studies. The efficacy of maintenance antidepressants is supported by a large body of evidence. The size effect of drug versus placebo difference used to prevent recurrence of unipolar or bipolar affective disease is comparable to the size effect of drug versus placebo difference for the treatment of an acute episode.lld:pubmed
pubmed-article:8290662pubmed:languageenglld:pubmed
pubmed-article:8290662pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8290662pubmed:citationSubsetIMlld:pubmed
pubmed-article:8290662pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8290662pubmed:statusMEDLINElld:pubmed
pubmed-article:8290662pubmed:issn0048-5764lld:pubmed
pubmed-article:8290662pubmed:authorpubmed-author:DavisJ MJMlld:pubmed
pubmed-article:8290662pubmed:authorpubmed-author:WangZZlld:pubmed
pubmed-article:8290662pubmed:authorpubmed-author:JanicakP GPGlld:pubmed
pubmed-article:8290662pubmed:issnTypePrintlld:pubmed
pubmed-article:8290662pubmed:volume29lld:pubmed
pubmed-article:8290662pubmed:ownerNLMlld:pubmed
pubmed-article:8290662pubmed:authorsCompleteYlld:pubmed
pubmed-article:8290662pubmed:pagination175-81lld:pubmed
pubmed-article:8290662pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:8290662pubmed:meshHeadingpubmed-meshheading:8290662-...lld:pubmed
pubmed-article:8290662pubmed:meshHeadingpubmed-meshheading:8290662-...lld:pubmed
pubmed-article:8290662pubmed:meshHeadingpubmed-meshheading:8290662-...lld:pubmed
pubmed-article:8290662pubmed:meshHeadingpubmed-meshheading:8290662-...lld:pubmed
pubmed-article:8290662pubmed:meshHeadingpubmed-meshheading:8290662-...lld:pubmed
pubmed-article:8290662pubmed:year1993lld:pubmed
pubmed-article:8290662pubmed:articleTitleA quantitative analysis of clinical drug trials for the treatment of affective disorders.lld:pubmed
pubmed-article:8290662pubmed:affiliationIllinois State Psychiatric Institute, Chicago 60651.lld:pubmed
pubmed-article:8290662pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8290662pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8290662pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:8290662pubmed:publicationTypeMeta-Analysislld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8290662lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8290662lld:pubmed